J.D. Rubright is vice president, Office of Research, National Board of Medical Examiners, Philadelphia, Pennsylvania.
T.Q. Ong is psychometrician, Psychometrics and Data Analysis, National Board of Medical Examiners, Philadelphia, Pennsylvania.
Acad Med. 2022 Aug 1;97(8):1219-1225. doi: 10.1097/ACM.0000000000004713. Epub 2022 Jul 21.
A testing program's decision making on retake policy considers a number of factors, including fairness to examinees, examination security, examination purpose, and classification accuracy. For high-stakes licensure and certification examinations charged with protection of the public, this includes balancing fairness issues inherent in the potential for false negatives with the public protection need to minimize false positives. Since 2012, the United States Medical Licensing Examination (USMLE) has maintained a policy of ≤ 6 attempts on any examination component. The purpose of this study was to empirically examine the appropriateness of existing USMLE retake policy.
A sample of over 300,000 examinees who were administered each Step examination between 2008 and 2018 was examined to address how pass rates (per attempt and cumulatively) differed for examinees and examinee subgroups via graphic depictions of pass rates, the impact of restricting the number of attempts on examinees and examinee subgroups via logistic regression analyses, and the impact of restricting the number of attempts on classification error via classification error analyses.
Repeaters displayed consistently lower pass rates on subsequent attempts. Regardless of Step, most passing examinees did so by their fourth attempt. Models predicting the log odds of examinees taking ≥ 5 attempts showed a significant effect of gender, race, and medical school status, although the associated sample sizes are small. Misclassification analyses showed that, as attempts increased, the percentage of false passers increased and percentage of false failers decreased.
These considerations led to the USMLE's decision to reduce its attempt limit from 6 to 4 on any Step or Step component effective July 2021. This change balances the competing interests of fairness and examination access to the examinee population, while simultaneously maintaining a minimum standard consistent with the mission of the USMLE program to protect the public.
测试计划的重考政策决策考虑了许多因素,包括考生的公平性、考试安全性、考试目的和分类准确性。对于承担保护公众责任的高风险许可和认证考试,这包括平衡潜在假阴性的公平问题与最小化假阳性的公众保护需求之间的平衡。自 2012 年以来,美国医师执照考试(USMLE)一直维持着任何考试部分不超过 6 次尝试的政策。本研究的目的是实证检验现有的 USMLE 重考政策的适当性。
对 2008 年至 2018 年期间参加每一步考试的超过 300,000 名考生的样本进行了检查,以通过图形表示的通过率来了解考生和考生亚组的通过率(每次尝试和累积)如何不同,通过逻辑回归分析来了解限制尝试次数对考生和考生亚组的影响,以及通过分类错误分析来了解限制尝试次数对分类错误的影响。
重考生在随后的尝试中始终显示出较低的通过率。无论在哪个步骤,大多数通过考试的考生都是在第四次尝试时通过的。预测考生尝试次数≥5 的对数几率的模型显示出性别、种族和医学院地位的显著影响,尽管相关的样本量较小。分类错误分析表明,随着尝试次数的增加,错误通过者的百分比增加,错误未通过者的百分比减少。
这些考虑因素导致 USMLE 决定自 2021 年 7 月起将其任何步骤或步骤组成部分的尝试限制从 6 次减少到 4 次。这一变化平衡了考生群体的公平性和考试准入的竞争利益,同时保持与 USMLE 计划保护公众的使命相一致的最低标准。